explore -WSS

explore

author：Wikipedia 2025-10-01 23:58:57 - browse：69983

WASHINGTON — For those already felled by fumes from the Brazilian Blowout, it might be small consolation, but lawmakers are pushing ahead with a campaign for better oversight of the beauty business.

Despite its booming growth, the cosmetics industry in the US has been virtually unregulated. The Food, Drug, and Cosmetic Act, adopted in 1938, essentially allowed personal care product companies to self-police.

But rising public concern over bad reactions to makeup, hair dyes, and fragrances, as well as evidence of long-term health risks from some of their chemical contents, has led lawmakers to try to toughen the regulatory framework for the $60 billion enhancement industry.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： FDA panel endorses Alnylam’s heart drug — after picking it apart

leisure time

WSS

Food makers tried to stack nutrition panel with preferred experts

New weight loss drugs vying to be the next Wegovy or Mounjaro

Biden report: The neurospychology of memory and aging

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

A common UTI test for kids haunts adults as a traumatic 'nightmare'

'Revelatory' study finds a smoking impact that remains after quitting

focus

explore

entertainment

Alkermes shareholders re

Food makers to regulators: Ultra

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Diverse clinical trials: Why aren’t we there yet?

Supreme Court strikes down use of affirmative action

What we’ve learned from the Aduhelm mess

Psychedelics group wrestles with new pharma identity

How housing is health care on Long Island

After affirmative action ruling, medical educators look to 'holistic review'

Food makers to regulators: Ultra

entertainment

Doctors' information doesn't help them choose wisely when sick

For Medicare Advantage, Democrats want stronger protections around AI

Biden report: The neurospychology of memory and aging

How digital tools helped lower hypertension in marginalized patients

FDA proposes changes to key medical devices approval pathway

Acelyrin, a rare IPO success, stumbles in its first big test

leisure time

leisure time

hotspot

leisure time